Comparison of cardiac output measurements between NICO and the pulmonary artery catheter during repeat surgery for total hip replacement

Eur J Anaesthesiol. 2007 Dec;24(12):1028-33. doi: 10.1017/S026502150700110X. Epub 2007 Aug 3.

Abstract

Objective: The aim of this study was to compare cardiac output measurements of the non-invasive cardiac output and the pulmonary artery catheter during repeat surgery for hip replacement.

Methods: In this prospective observational study, patients undergoing repeat hip surgery who needed a pulmonary artery catheter were included. A standard protocol was followed for induction, endotracheal intubation and maintenance of anaesthesia (sufentanil, etomidate, sevoflurane, cisatracurium). After endotracheal intubation, the non-invasive cardiac output was connected and a pulmonary artery catheter was inserted. Data were collected every 3 min until patients were extubated.

Results: Ten patients were included and 2455 points of comparison recorded. Cardiac output from the pulmonary artery catheter varied from 1.7 to 8.9 L min(-1) (mean 4.1 L min(-1)) and the non-invasive cardiac output (using averaging mode) from 1.7 to 8.0 L min(-1) (mean 3.7 L min(-1)). There was a significant correlation between them (P < 0.01; bias 0.3 L min(-1); limits of agreement +1.9 and -2.5 L min(-1)), although these differed between patients.

Conclusion: The perioperative bias was small and the non-invasive cardiac output slightly underestimated cardiac output intraoperatively compared to the pulmonary artery catheter. The bias was smaller when mean cardiac output was below 3 L min(-1). Core temperature between 34.4 degrees C and 37.6 degrees C had no influence on the differences.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anesthetics, Inhalation / therapeutic use
  • Anesthetics, Intravenous / therapeutic use
  • Arthroplasty, Replacement, Hip*
  • Atracurium / analogs & derivatives
  • Atracurium / therapeutic use
  • Cardiac Output / physiology*
  • Catheterization, Swan-Ganz / methods*
  • Etomidate / therapeutic use
  • Female
  • Hip Prosthesis
  • Humans
  • Intubation, Intratracheal
  • Male
  • Methyl Ethers / therapeutic use
  • Monitoring, Intraoperative / methods*
  • Neuromuscular Blocking Agents / therapeutic use
  • Prospective Studies
  • Reoperation
  • Sevoflurane
  • Software*
  • Sufentanil / therapeutic use

Substances

  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Methyl Ethers
  • Neuromuscular Blocking Agents
  • Atracurium
  • Sevoflurane
  • Sufentanil
  • cisatracurium
  • Etomidate